Lion Of Japan to Market Bufferin Aspirin Brand To Compete With Pabron
This article was originally published in PharmAsia News
Executive Summary
Japan's Lion said it would begin marketing a cold medicine brand to compete with Taisho Pharmaceutical's best-seller Pabron (carbocisteine)